Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,241 | -89,516 | -95,275 | -82,410 | N/A |
| Depreciation Amortization | 463,004 | 358,325 | 237,832 | 118,595 | N/A |
| Income taxes - deferred | -196,782 | -150,828 | -116,454 | -85,409 | -143,371 |
| Accounts receivable | -103,863 | -35,893 | 6,079 | 1,477 | N/A |
| Other Working Capital | 123,977 | 28,082 | 12,118 | -42,153 | -5,215 |
| Other Operating Activity | -18,564 | -45,454 | -58,708 | -25,547 | 870,400 |
| Operating Cash Flow | $193,531 | $64,716 | $-14,408 | $-115,447 | $721,814 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -112,681 | -78,999 | -53,571 | -28,243 | N/A |
| Purchase Of Investment | -566,068 | -457,932 | -198,650 | -99,602 | N/A |
| Sale Of Investment | 574,145 | 389,165 | 190,986 | 146,224 | N/A |
| Other Investing Activity | -55,604 | -20,935 | -20,357 | -5,214 | 0 |
| Investing Cash Flow | $-160,208 | $-168,701 | $-81,592 | $13,165 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 180,379 | 150,388 | 95,150 | 71,589 | N/A |
| Financing Cash Flow | $180,379 | $150,388 | $95,150 | $71,589 | $N/A |
| Beginning Cash Position | 337,682 | 337,682 | 337,682 | 337,682 | N/A |
| End Cash Position | 551,384 | 384,085 | 336,832 | 306,989 | N/A |
| Net Cash Flow | $213,702 | $46,403 | $-850 | $-30,693 | $721,814 |
| Free Cash Flow | |||||
| Operating Cash Flow | 193,531 | 64,716 | -14,408 | -115,447 | 721,814 |
| Capital Expenditure | -112,681 | -78,999 | -53,571 | -28,243 | N/A |
| Free Cash Flow | 80,850 | -14,283 | -67,979 | -143,690 | 721,814 |